These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 7833294)
1. Therapy of cancer metastasis by systemic activation of macrophages. Fidler IJ Adv Pharmacol; 1994; 30():271-326. PubMed ID: 7833294 [No Abstract] [Full Text] [Related]
2. Stimulation of host resistance to metastatic tumors by macrophage activating agents encapsulated in liposomes. Kirsh R; Poste G Adv Exp Med Biol; 1983; 162():69-75. PubMed ID: 6869097 [No Abstract] [Full Text] [Related]
3. [The role of macrophages in the anti-tumor resistance of the body in metastasis]. Umanskiĭ VIu Eksp Onkol; 1989; 11(6):11-6. PubMed ID: 2684604 [TBL] [Abstract][Full Text] [Related]
4. [Basic characteristics of macrophage as an effector cell]. Voĭtenkov BO; Okulov VB Vestn Ross Akad Med Nauk; 1995; (4):59-64. PubMed ID: 7780345 [No Abstract] [Full Text] [Related]
5. Macrophages and cancer metastasis. Fidler IJ; Poste G Adv Exp Med Biol; 1982; 155():65-75. PubMed ID: 6984285 [TBL] [Abstract][Full Text] [Related]
6. Eradication of cancer metastasis by tumoricidal macrophages. Fidler IJ Adv Exp Med Biol; 1988; 233():415-23. PubMed ID: 3223395 [No Abstract] [Full Text] [Related]
7. Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators. Killion JJ; Fidler IJ Pharmacol Ther; 1998 Jun; 78(3):141-54. PubMed ID: 9690815 [TBL] [Abstract][Full Text] [Related]
8. [The role of macrophages in tumor growth]. Okulov VB; Voĭtenkov BO Vopr Onkol; 1990; 36(10):1170-8. PubMed ID: 2251810 [No Abstract] [Full Text] [Related]
9. Therapy of cancer metastasis by systemic activation of macrophages: from the bench to the clinic. Fidler IJ; Kleinerman ES Res Immunol; 1993 May; 144(4):284-7; discussion 294-8. PubMed ID: 8378598 [No Abstract] [Full Text] [Related]
10. The generation of tumoricidal activity in macrophages for the treatment of established metastases. Fidler IJ Symp Fundam Cancer Res; 1983; 36():421-35. PubMed ID: 6382518 [No Abstract] [Full Text] [Related]
11. Macrophage content of tumours in relation to metastatic spread and host immune reaction. Eccles SA; Alexander P Nature; 1974 Aug; 250(5468):667-9. PubMed ID: 4546859 [No Abstract] [Full Text] [Related]
13. Macrophage therapy of cancer metastasis. Fidler IJ Ciba Found Symp; 1988; 141():211-22. PubMed ID: 3075934 [TBL] [Abstract][Full Text] [Related]
14. Macrophages in cancer metastases and their relevance to metastatic growth. Key ME Cancer Metastasis Rev; 1983; 2(1):75-88. PubMed ID: 6352008 [TBL] [Abstract][Full Text] [Related]
16. The alternatively activated human--redux. Scott AL J Infect Dis; 2009 Jun; 199(12):1723-5. PubMed ID: 19456228 [No Abstract] [Full Text] [Related]
17. Prevention of tumor metastasis after surgical removal of primary tumor by using in vitro activated macrophages. Okuno K; Hashimoto T; Qian JH; Tsuchida T; Fujiwara H; Hamaoka T Jpn J Clin Oncol; 1985 Mar; 15(1):87-94. PubMed ID: 3981817 [TBL] [Abstract][Full Text] [Related]
18. Tumor versus tumor-associated macrophages: how hot is the link? Guruvayoorappan C Integr Cancer Ther; 2008 Jun; 7(2):90-5. PubMed ID: 18550889 [TBL] [Abstract][Full Text] [Related]
20. A study of interactions among markers of macrophage functions in metastatic solid tumors: neopterin levels in relation to those of tumor necrosis factor-alpha and of soluble interleukin-2 receptors. Lissoni P; Brivio F; Fumagalli L; Galimberti C; Cataldo M; Marsili MT; Brivio O; Barni S; Tancini G; Angelini A J Biol Regul Homeost Agents; 1994; 8(1):32-5. PubMed ID: 7976492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]